trans-3-(4-Methoxyphenyl)-N-(pentan-3-yl)acrylamide
| Names | |
|---|---|
| Other names
TMPPAA | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| EC Number |
|
PubChem CID |
|
| |
| |
| Properties | |
| C15H21NO2 | |
| Molar mass | 247.338 g·mol−1 |
| Hazards | |
| GHS labelling: | |
| Warning | |
| H302 | |
| P264, P270, P301+P317, P330, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
trans-3-(4-Methoxyphenyl)-N-(pentan-3-yl)acrylamide, commonly referred as TMPPAA, is a allosteric agonist and positive allosteric modulator (PAM) of 5-HT3 receptor. It has the molecular formula C15H21NO2. TMPPAA behaves as both an agonist and a PAM at 5-HT3A receptors, not via binding at the orthosteric site.[1]
Pharmacology and mechanism of action
[edit]It is a synthetic compound that functions as an allosteric agonist and positive allosteric modulator of the 5-HT3 serotonin receptor. While traditional ligands bind to the extracellular orthosteric site, chimeric and mutational studies indicate that TMPPAA interacts directly with the receptor's transmembrane domain. Electrophysiological experiments show that the compound exhibits distinct desensitization kinetics and causes a progressive current run-down, demonstrating a mechanism of activation separate from serotonin.[1][2]
References
[edit]- 1 2 "Merck-TMPPAA".
- ↑ Gasiorek, Agnes; Trattnig, Sarah M.; Ahring, Philip K.; Kristiansen, Uffe; Frølund, Bente; Frederiksen, Kristen; Jensen, Anders A. (June 2016). "Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors". Biochemical Pharmacology. 110–111: 92–108. doi:10.1016/j.bcp.2016.04.004. PMID 27086281.
